dr. george demetri describes the mechanism of action of regorafenib in gist
Published 12 years ago • 1.1K plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
1:23
dr. george demetri discusses regorafenib for patients with gist trial results
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
0:42
dr. keedy on regorafenib for the treatment of gist
-
11:24
managing toxicities associated with regorafenib
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
9:34
regorafenib in colorectal cancer
-
12:53
gist 2010 - dr. george demetri
-
1:29
dr. demetri on larotrectinib in trk-fusion gi cancers
-
5:28
project flag: families learning about gist - dana-farber cancer institute
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
6:15
adjuvant treatment in gastrointestinal stromal tumor (gist)
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
5:31
practical advice for using regorafenib
-
7:35
use of regorafenib in refractory mcrc
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer